Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr 9;9(4):e93869.
doi: 10.1371/journal.pone.0093869. eCollection 2014.

Effects of early life paracetamol use on the incidence of allergic disease and sensitization: 5 year follow-up of an Ethiopian birth cohort

Affiliations

Effects of early life paracetamol use on the incidence of allergic disease and sensitization: 5 year follow-up of an Ethiopian birth cohort

Alemayehu Amberbir et al. PLoS One. .

Abstract

Introduction: The hypothesis that paracetamol, one of the most widely used medicines, may increase the risk of asthma and allergic disease is of obvious importance but prospective cohort data looking at dose and timing of exposure are lacking.

Objective: The aim of the study is to investigate the role of paracetamol use in early life on the prevalence and incidence of wheeze, eczema, rhinitis and allergic sensitization, prospectively over 5 years in an Ethiopian birth cohort.

Methods: In 2005/6 a birth cohort of 1006 newborns was established in Butajira, Ethiopia. Questionnaire data on allergic disease symptoms, paracetamol use and numerous potential confounders were collected at ages 1, 3 and 5, and allergen skin sensitivity measured at ages 3 and 5. Multivariate logistic regression was used to determine independent effects of paracetamol exposure on the incidence of each outcome between ages 3 and 5, and prevalence at age 5.

Findings: Paracetamol use in the first 3 years of life was reported in 60% of children and was associated with increased incidence of wheeze, eczema, rhinitis and allergic sensitisation between ages 3 and 5 which was statistically significant for wheeze and eczema. High exposure (reported use in the past month at age 1 and 3) was associated with a more than 3-fold increased risk of new onset wheeze (adjusted odds ratio (OR) 3.64; 95% confidence interval, 1.34 to 9.90) compared to never users. Use in the past year at age 3 but not age 1 was associated with ORs at least as large as those for use in first year of life only. Significant positive dose-response effects of early life use were seen in relation to the prevalence of all outcomes at age 5.

Conclusions: Use of paracetamol in early life is a strong risk factor for incident allergic disease in childhood.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow chart showing reporting of symptom outcome measures and sensitization between 1 and 5 years.

Similar articles

Cited by

References

    1. Eder W, Ege MJ, von Mutius E (2006) The Asthma Epidemic. N Engl J Med 355(21): 2226–2235. - PubMed
    1. Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, et al. (1997) Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 350(9071): 85–90. - PubMed
    1. Asher MI, Montefort S, Bjorksten B, Lai CKW, Strachan DP, et al. (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537): 733–743. - PubMed
    1. Moffat MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, et al. (2010) A Large-Scale, Consortium-Based Genome wide Association Study of Asthma. N Engl J Med 363(13): 1211–1221. - PMC - PubMed
    1. Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson W, et al. (2011) Exposure to Environmental Microorganisms and Childhood Asthma. N Engl J Med 364(8): 701–709. - PubMed

Publication types

MeSH terms